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Mouse macrophages express several distinct plasma membrane receptors for 
the Fc domain of IgG  (1).  The most numerous and best characterized is the 
trypsin-resistant Fc receptor (FcR) 1 specific for IgG1 and IgG2b. The receptor 
is a 60-kD transmembrane glycoprotein (2, 3) involved in a variety of macrophage 
host defense functions, such as the release of potent cytotoxic and inflammatory 
agents, the pinocytosis of soluble immune complexes, and the phagocytosis of 
large IgG-coated particles (1). 
Previous studies of FcR-mediated endocytosis have shown that certain ligands 
can modulate the cell surface expression of the receptor (4-6).  Internalization 
of soluble or particulate IgG-containing immune complexes is accompanied by 
the net loss of FcR from the cell surface. Both receptor and ligand are degraded, 
presumably in lysosomes, and de novo synthesis is required to restore the original 
number of surface FcR (6). On the other hand, when the ligand is a monovalent 
Fab fragment of the antireceptor antibody 2.4G2 (7), FcR-Fab complexes rapidly 
recycle between the cell surface and a nonlysosomal endocytic compartment, i.e., 
endosomes (5). There is no decrease in the number of surface receptors and no 
acceleration in the rate of receptor degradation. 
Many  basic  questions  remain  unanswered  regarding  the  control  of  FcR- 
mediated endocytosis in macrophages. The pathways and organelles involved in 
the uptake of receptor-ligand complexes have been only superficially character- 
ized (8),  and the intracellular fate of the receptor during IgG complex uptake 
has yet to be directly shown. In addition, the mechanism by which the multivalent 
antibody-antigen complexes prevent FcR recycling, in contrast to the behavior 
of the monovalent antireceptor Fab, is of particular interest. While the different 
valencies of these two iigands have been suggested to play a  role (6),  it is clear 
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that IgG complexes and anti-FcR Fab also differ in their modes of attachment 
to the receptor. Conceivably, the signal that results in FcR degradation and down 
regulation is provided by the binding of intact Fc domains rather than by the 
aggregation  of adjacent  receptors  by  multivalent  ligands.  In  this  paper,  we 
characterize the internalization and intracellular fate of FcR bound to either IgG 
complexes or multivalent preparations  of 2.4G2  Fab in  the J774  macrophage 
cell  line using both  biochemical and  morphological techniques.  We show that 
multivalent FcR-bound ligands are taken up via coated pits, coated vesicles, and 
endosomes, and result in the delivery of both receptor and ligand to lysosomes. 
Since multivalent Fab preparations were as effective as IgG-containing immune 
complexes at mediating lysosomal transport, these data support the concept that 
ligand  valency,  and  not  the  presence  of intact  Fc  domains,  is  an  important 
determinant of FcR transport during receptor-mediated endocytosis. 
Materials and Methods 
Cells and Cell Culture.  The mouse macrophage-like cell line, J774, was maintained in 
suspension culture as described previously (5). For experiments, cells were plated on 10- 
cm tissue culture dishes (107 cells per dish) or on 16-ram wells (5 x  105 cells per well) for 
1 h at 37°C in alpha-modified Eagle's medium containing 8%  FCS and  10 mM Hepes 
buffer at pH 7.4. 
Antibodies  and Antibody-Antigen  Complexes.  Affinity purified rabbit anti-DNP IgG was 
prepared as described (9). Immune complexes were formed just before use by incubating 
anti-DNP IgG (20 #g]ml) with DNP-modified BSA (DNP-BSA;  >12 DNP groups/BSA 
molecule) (9) at an IgG/BSA molar ratio of 2.5:1  (6). Incubations were performed at 
37°C or at  room  temperature  for 30-60  rain. The  monoclonal rat anti-mouse FcR 
antibody, designated 2.4G2, was grown as ascites and purified as described (2,  7).  Fab 
fragments 2.4G2  were  prepared  by papain  digestion and purified by DEAE-cellulose 
chromatography and Sephadex  G-50  (Pharmacia Fine Chemicals, Piscataway,  NJ)  gel 
filtration (7). The antibody preparations were analyzed by SDS-PAGE and by HPLC using 
an Ultro-Pac TSK-G 3000-SW column (LKB, Bromma, Sweden) and found to be homo- 
geneous. Anti-DNP IgG, DNP-BSA, and 2.4G2 Fab were labeled with Na~2~I (10 mCi/ml, 
0.5 mCi/50 t*g protein; Amersham Corp., Arlington Heights, IL) using Iodogen (Pierce 
Chemical  Co.,  Chicago,  IL) as  described  (4). Monospecific rabbit  anti-FcR antisera, 
produced against purified, SDS-denatured receptor, was used for immunoprecipitation 
without purification. These antisera detect free receptor and receptor-ligand complexes 
with equal efficiency (4, 6). 
Preparation of Colloidal  Gold Conjugates.  Colloidal gold was prepared  by sonication 
under conditions that generated particles 5-10 nm in diameter (10). Stable gold conjugates 
of DNP-BSA and 2.4G2 Fab were made by incubating Img of either protein (containing 
trace amounts of ~25I) with 18 ml of colloidal gold for 3 min at room temperature. The 
reaction was stopped with 2 ml of 1% PEG 20,000.  The gold particles were pelleted by 
centrifugation in an SW 40 rotor at 39,000 rpm for 1 h at 4°C. The pellet was resuspended 
in 0.2% PEG in PBS and centrifuged again. The final pellet was resuspended in 0.5 ml of 
0.2%  PEG  in  PBS  containing 0.02%  NaNs.  The  concentration of BSA  or  Fab  was 
calculated from the recovered radioactivity. Both gold conjugates were judged by electron 
microscopy to be monodisperse and remained stable for several  weeks at 4°C. For some 
experiments,  DNP-BSA-gold  and  Fab-gold conjugates were  radioiodinated after their 
formation using Iodogen (4). 
Colloidal gold-labeled immune complexes for electron microscopy were formed exactly 
as described above for the unconjugated immune complexes, except that DNA-BSA-gold 
was used in place of DNP-BSA. 
Binding and  Internalization  Assays.  To distinguish between cell  surface-bound and 
internalized IgG/DNP-BSA complexes, cell  monolayers incubated with J2~I-IgG/DNP- 954  MACROPHAGE  Fc  RECEPTORS  AND  Fc  RECEPTOR-BOUND  L|GANDS 
BSA were treated with 1 mg/ml subtifisin (Sigma Chemical Co., St. Louis, MO) for 2 h at 
4°C, conditions that remove 80-90%  of surface-bound complexes (6).  In experiments 
designed to measure  the  degradation of internalized ligand,  immune  complexes were 
prepared using ~25I-DNP-BSA since IgG is relatively resistant to lysosomal proteolysis (6). 
Cell Fractionation.  After incubation in the appropriate ligand, cell monolayers were 
washed with cold PBS, harvested by scraping, and combined with 108 unlabeled J774 cells 
obtained from suspension culture. Homogenates were prepared using a  stainless  steel 
Dounce homogenizer (Kontes Co., Vineland, N  J), the homogenate centrifuged at 750 g 
for  10  min  at  4°C,  and  the  postnuclear  supernatant  centrifuged in  27%  Percoll as 
described (11).  Centrifugation was performed using Quick-Seal tubes (Beckman Instru- 
ments,  Inc.,  Palo Alto, CA) in  either a  Beckman  70 Ti rotor (2  h,  16,000 rpm) or a 
Beckman VTiS0 rotor (1  h,  18,000 rpm).  1-ml fractions were collected, and ~25I deter- 
mined using a  Beckman gamma counter. ~-Glucuronidase and horseradish peroxidase 
activities were measured spectrophotometrically in the presence of 0.I % Triton X-100 
(11). 
Immunoprecipitation.  J774 cells were plated in 35-ram dishes (106 cells per dish)  and 
radioiodinated at 4°C using lactoperoxidase and glucose oxidase (12). Labeled cells were 
then incubated at  37°C in complete medium in the presence or absence of saturating 
concentrations of IgG/DNP-BSA immune complexes (20 ~g/ml) (6) or 2.4G2 Fab (either 
free or colloidal gold-conjugated, 3-5 ~g/ml) (2). After 1-2 h, monolayers were washed 
with cold PBS, harvested by scraping, and collected by centrifugation (750 g, 4°C). Cell 
pellets were combined with  107 unlabeled cells, homogenized, and fractionated by cen- 
trifugation in Percoll density gradients as above, l-ml fractions were collected and lysed 
at  4°C  in  PBS containing 0.5%  Triton X-100,  1 mM  PMSF,  10  mM  leupeptin, and 
aprotinin (13). FcR was immunoprecipitated as described previously using conditions that 
were optimized to ensure >80% recovery of ~eSI-FcR (3). Briefly, 2 t~l of a rabbit anti- 
FcR antiserum was  added per  1-ml  fraction (4°C,  1 h)  followed by  I0  ul  of affinity- 
purified goat anti-rabbit  IgG (Boehringer Mannheim Diagnostics,  Inc.,  Houston, TX) 
(final concentration 10 ~g/ml, 4 °C,  1 h). Immune complexes were collected using fixed 
Staphyloccocus aureus (Zymed Laboratories, So. San Francisco, CA).  ~2~I-FcR was stripped 
from the immunoadsorbant in electrophoresis sample buffer containing 2% SDS (100°C, 
5  rain),  S.  aureus  removed  by  centrifugation,  and  the  supernatant  applied  to  SDS- 
polyacrylamide minigels (4-11% acrylamide gradients). After electrophoresis, gels were 
dried, autoradiographed, and the radioactive bands cut out for quantitation (13). 
Electron Microscopy.  J774 cells were plated on  16-mm wells as confluent monolayers 
2-3 h before use. The cells were incubated with gold-labeled ligands in 0.2 ml of complete 
medium at 37 °,  17 °, or 4°C for various times. For some experiments, incubations were 
performed in the presence of 100 or 200 ug/ml of 2.4G2 IgG (or Fab) to block binding 
to  FcR.  After  extensive  washing  with  cold  PBS,  monolayers  were  fixed  with  2.5% 
glutaraldehyde in 0.05 M sodium cacodylate buffer (pH 7.4,  30 min), postfixed in 2% 
OsO4 (2 h, 4°C), and block-stained with 0.5% uranyl acetate. Samples were then dehy- 
drated with ethanol and embedded in Epon. Sections were stained with uranyl acetate 
and  lead citrate, and examined with a JEM-100CX  electron microscope (JEOL USA, 
Peabody, MA). 
Results 
Pathway of FcR-mediated Endocytosis.  For electron microscopic identification 
of  the  organelles  involved  in  FcR-mediated  endocytosis,  a  soluble  immune 
complex containing colloidal gold was used.  DNP-BSA was first adsorbed to 5- 
10-nm colloidal gold particles.  Affinity-purified anti-DNP  IgG was then added 
(2.5:1  IgG/BSA molar ratio) to yield IgG/DNP-BSA immune complexes on the 
surface of the gold particles. Prepared in this way, the resulting gold-labeled IgG 
complexes closely resembled the receptor's physiological ligand (6). 
Using  conjugates  prepared  with  ~25I-anti-DNP  IgG  or  ~25I-DNP-BSA,  gold- UKKONEN  ET  AL.  955 
labeled immune complexes were shown to bind specifically to FcR on J774 cells. 
First, monolayers were incubated with saturating concentrations of the conjugate 
(20 #g/ml IgG) for 2 h  at 4°C in the presence or absence of excess 2.4G2,  an 
antireceptor mAb that selectively blocks the binding of immune complexes to 
FcR (2,  6).  Binding of both  125I-IgG/DNP-BSA-gold and  IgG/I~SI-DNP-BSA- 
gold was >90% inhibited by either 2.4G2 IgG or Fab (100 #g/ml). This inhibition 
was confirmed by electron microscopy: the number of gold particles observed 
on  the plasma membrane of cells exposed to IgG/DNP-BSA-gold at 4°C was 
reduced  10-fold  by  simultaneous incubation  with  100  t~g/ml  2.4G2  IgG.  In 
addition, ~ 106 molecules of IgG bound per J774 cell irrespective of whether the 
anti-DNP  IgG  had  been  complexed with  DNP-BSA-gold  or  free  DNP-BSA, 
indicating that the presence of colloidal gold did not greatly affect the attachment 
properties of immune complexes. Finally, J774 cells did not accumulate free lzsI- 
DNP-BSA-gold (i.e.,  DNP-BSA-gold not complexed with  anti-DNP  IgG) even 
after 2 h at 4 ° or 37 ° C, indicated both by measuring cell-associated radioactivity 
and by electron microscopy. Thus, the colloidal gold preparations used in these 
studies did not adsorb nonspecifically to the J774 cell plasma membrane. 
When viewed in thin sections by electron microscopy, gold-labeled complexes 
bound to J774  cells at 4°C were seen on the plasma membrane often in small 
clusters and only occasionally at coated pits. After 5 rain at 37°C, however, they 
were distributed mainly in coated pits, coated vesicles, and in peripheral tubules 
and vesicles characteristic of endosomes (Fig.  1,A-D, see also Fig. 7 A). After 15 
min, the majority of the gold was found in larger endosomal vacuoles located in 
both  the peripheral and perinuclear cytoplasm (Fig.  1,  E  and F,  see also Fig. 
7A). The gold was always closely associated with either the limiting membrane 
of these endosomes or,  more frequently, with the surfaces of their membrane 
inclusions. IgG-gold was only occasionally seen in dense, lysosome-like vesicles at 
early time points. After 1 h, however, most of the gold was found in condensed 
multivesicular  bodies  and  electron  dense  lysosomes  where  it  was  no  longer 
preferentially associated with membranes (Fig.  1, G and H). J774 cell lysosomes 
are easily identified by their electron-dense contents and characteristic membra- 
nous inclusions. 
The morphological data showed that the internalization of multivalent FcR- 
bound ligands proceeded via the standard pathway described for a  variety of 
other plasma membrane receptors: passage through coated pits, coated vesicles, 
peripheral and perinuclear endosomes, and finally lysosomes (14-16). The data 
also suggested that IgG complexes, as previously shown for epidermal growth 
factor (17), were concentrated on the internal membrane inclusions of multive- 
sicular endosomes and that  they remained largely membrane-bound until the 
point of delivery to lysosomes. 
Subcellular Localization of IgG  Complexes.  To  follow  the  transport  of FcR 
bound ligands by cell  fractionation,  125I-IgG/DNP-BSA  complexes were used 
without the colloidal gold label (6). J774 cells were first incubated with saturating 
concentrations of ligand  (20  /~g/ml  IgG)  in  the cold or at  37°C  for varying 
lengths of time,  whereafter the  monolayers were washed,  homogenized, and 
centrifuged in Percoll density gradients. As shown in Fig. 2A, 12~I-IgG complexes 
that were bound to the plasma membrane at 4°C, sedimented as a symmetrical 956  MACROPHAGE  Fc  RECEPTORS  AND  Fc  RECEPTOR-BOUND  LIGANDS 
FIGURE  l.  Electron  microscopic localization of IgG/DNP-BSA-gold internalized at  37°C. 
J774 cell monolayers were incubated with IgG/DNP-BSA gold (20 #g IgG/ml; 5 nm gold) for 
various times at 37°C. After 5 min incubation, the gold particles were seen in coated pits (A), 
which  were  often  deeply  invaginated  (B),  coated  vesicles (B,  C),  and  in  small  peripheral 
endosomes  (D).  Within  15  min,  the  complexes were  found  in  peripheral  and  perinuclear 
endosomes,  many  of which  contained  internal  vesicles (E).  After 60  rain,  the  marker  was 
localized in  larger multivesicular bodies (F),  more condensed  multivesicular structures  (G), 
and  in  mature,  dense lysosomes (H).  In multivesicular bodies (E, F), the gold was  typically 
located on the membrane of the small inner vesicles, while in the more condensed multive- 
sicular bodies (G) and electron-dense lysosomes (H) the gold particles were apparently free in 
the matrix. Bar, 0.2 #m. UKKONEN  ET  AL.  957 
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125  FIGURE 2.  Sedimentation of cell-associated  I-IgG/DNP-BSA in Percoll density gradients. 
7  125  --  Confluent 10-cm dishes ofJ774 cells (10  cells/dish) were incubated with  I-IgG/DNP-BSA 
at 0°C for 60 rain (A), or at 37°C for 10 rain (B), 20 rain (C), or 60 rain (D). The cells were 
then washed, harvested by scraping,  combined with  108 unlabeled cells, and homogenized. 
The posmuc[ear supernatants were centrifuged in 2'7% Percoll density gradients (I ! ). Fractions 
were collected from the bottom of the tube, ]~51 determined, and lysosomes localized using #- 
glucuronidase as the marker enzyme (broken  line in B).  Surface-bound  1251-IgG complexes 
sedimented as a  sharp  light density peak (0 =  1.03  g/ml) near the top of the gradient (A). 
Following internalization at  37°C,  the complexes shifted  progressively to the high density 
4  125  lysosomal fractions (0 =  1.09 g/ml) (B-D). 3-6 X 10  cpm of  I were applied to each gradient. 958  MACROPHAGE  Fc  RECEPTORS  AND  Fc  RECEPTOR-BOUND  LIGANDS 
low density peak (p =  1.03 g/ml) near the top of the gradient. After 10 rain at 
37°C, however, ~10%  of the radioactivity was found in high density fractions 
cosedimenting with  the  lysosomal  marker enzyme /3-glucuronidase (Fig.  2B). 
The low density peak had also become broader and asymmetric, exhibiting a 
shoulder of intermediate density. Since at this time point >40% of cell-associated 
IgG complexes were intracellular (i.e., resistant to removal by subtilisin) (6), the 
shoulder was likely to reflect the presence of internalized ligand in endosomes 
known to sediment as a  broad band of low to intermediate density (11).  After 
20 rain, at which time approximately two-thirds of the ligand was intracellular, 
the gradient radioactivity was evenly divided between the low to intermediate 
density peak and the high density lysosomal peak (Fig. 2C). By 1 h, >70% of the 
internalized  z2~'I-IgG complexes had  been  transferred to  lysosomes (Fig.  2D). 
The kinetics of appearance of ligand in high density fractions are in agreement 
with  the  finding  that  degradation  of  IgG/125I-DNP-BSA  complexes  can  be 
detected within 5-10  min after internalization (6),  as well as with the electron 
microscopy that showed that most of the internalized IgG complexes were found 
in lysosomes only after 1 h of uptake (Fig.  1). 
Transport of Monomeric and Aggregated Anti-FcR Antibody.  Previous work has 
shown  that  a  monovalent  FcR-bound  ligand,  such  as  a  Fab  fragment of the 
antireceptor mAb 2.4G2,  is poorly transported to lysosomes (5).  125I-Fab binds 
efficiently to the receptor and is delivered to endosomes, but instead of contin- 
uing  to  lysosomes it  is  recycled back  to  the  cell  surface still  bound  to  FcR. 
Although it seems likely that the different fates of the monovalent Fab and the 
multivalent immune complexes are  due  to  their  different valencies,  the  two 
ligands also differ in how they bind to FcR, Fab via its antigen combining site 
and IgG complexes via the Fc domains of intact IgG molecules. To test whether 
the signal for transport to lysosomes depends on ligand valency or on mode of 
attachment to the receptor, we examined the endocytosis of multivalent com- 
plexes of v~sI-2.4G2 Fab. 
Multivalent Fab complexes were prepared by adsorption of the monovalent 
antibody fragments to colloidal gold particles. While the precise valency of the 
resulting conjugates could not be accurately determined, we estimate that be- 
tween 2 and 12 molecules of Fab adsorbed to individual gold particles which in 
these preparations  varied  in  diameter from  5  to  10  rim.  These figures were 
obtained from more accurate measurements using S. aureus protein A, a protein 
with a  Stokes radius similar to an IgG Fab  fragment (18) (H. Geuze, personal 
communication). The  ~2~I-Fab-gold conjugate bound specifically to  FcR,  since 
binding to J774 cells (1  h, 4°C) could be inhibited up to 85% by simultaneous 
incubation with an excess of unconjugated 2.4G2 Fab or 2.4G2 IgG (200 ug/ml). 
Unlike unconjugated Fab, however, the Fab-gold could not be dissociated from 
the receptor by acidic pH (pH <  4.3) (5). 
Cells were incubated with  ~25I-Fab or a251-Fab-gold for  1 h  at 4°C or 37°C, 
homogenized, and centrifuged in Percoll density gradients. As shown in Fig. 3A, 
J  z~'I-Fab-gold  bound in the cold sedimented as a  single low density peak corre- 
sponding to  the plasma membrane. After  1 h  at  37°C,  however, most of the 
radioactivity was found in the high density region of the gradient, cosedimenting 
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FICURE 3.  Sedimentation of cell-associated J25I-2.4G2  Fab and  J~SI-Fah-gold conjugates in 
Percoll density  gradients.  Confluent 6-cm dishes of J774  cells were incubated  in complete 
medium containing 1251-Fab or 1251-Fab-gold (3-5  ug Fab]ml) for 60  rain at either 0°C or 
37 ° C. Monolayers were then washed with cold PBS, harvested by scraping, homogenized, and 
centrifuged in Percol[ as in Fig. 2. (A) Sedimentation of ~25I-Fab-gold bound to cells at 0°C 
(-0-) and of the lysosomal marker enzyme ¢3-glucuronidase  (--(3--). (B) The sedimentation 
of 125I-Fab-gold (-0-) and unconjugated 1251-Fab (--0--) after incubation with J774 cells at 
3 7 ° C. Profiles shown were taken from different gradients, except that 13-glucuronidase  activity 
was determined from the 37°C l~SI-Fah-go[d  gradient. The amounts of radioactivity applied 
125  o  5  125  0  to each gradient were:  I-Fab+gold  37  C, 0.8 ×  10  cpm;  l-Fab-gold 0  C, 0.4 X 10  cpm; 
125  5  unconjugated  I-Fab, 1.9 x  10  cpm. 80-90% of the radioactivity was recovered from each 
gradient. 
jugated ~2"~I-Fab sedimented predominantly in the low density plasma membrane- 
endosome region of the gradient (Fig. 3B). Since no attempt was made to remove 
surface-bound  ~zSI-Fab by treatment  with  pH  4  medium,  the  fraction  of cell- 
associated unconjugated  Fab (15%) which was in endosomes after  I  h  at 37°C 
could not be distinguished  from plasma membrane-bound  125I-Fab, which also 
sediments as a low density peak on Percoll gradients (5). Nevertheless, these data 
show that  unlike the monomeric  Fab, the gold conjugate was internalized  and 
transported  to  lysosomes  in  a  manner  similar  to  authentic  multivalent  IgG 
immune complexes. 
This conclusion was supported by electron microscopic examination  ofJ774 
cells exposed to Fab-gold for 5-60 rain at 37 ° C. As shown in Fig. 4, gold particles 960  MACROPHAGE  Fc  RECEPTORS AND  Fc  RECEPTOR-BOUND  LIGANDS 
FIGURE 4.  Localization of internalized 2.4G2 Fab-gold conjugates by electron microscopy. 
J774 monolayers were incubated with 2.4G2 Fab conjugated to 5-10-nm diameter particles 
of colloidal gold (Fab concentration 5 #g/ml). The general features of the uptake pathway 
were found to be similar to the uptake of IgG/DNP-BSA immune complexes (Fig. 1). After 5 
min at 37°C, Fab-gold was found in clathrin coated pits (A), coated vesicles  (B), as well as in 
multivesicular endosomes (D). By 1 h, almost all cell-associated  gold was localized in electron 
dense lysosomes (C), in agreement with the  Percoll gradient data (Fig. 3). The number of 
surface-bound and intracellular gold particles was decreased by 75-80%  in cells incubated 
simultaneously with Fab-gold and 100 vg/ml unconjugated 2.4G2 IgG. Bar, 0.2 t~m. 
were seen  in  coated pits,  coated  vesicles, endosomes,  and  electron-dense lyso- 
somes as already illustrated for gold-labeled IgG/DNP-BSA immune complexes 
in Fig.  1. Endocytosis was judged to be FcR-mediated since incubation with Fab- 
gold for 1 b at 37°C in the presence of 100/~g/ml unconjugated 2.4G2 reduced 
the number of cell-associated gold particles by 75%. 
Taken  together,  these results  give additional  support  to  the suggestion  that 
ligand valency, rather than the mode of attachment, determines the intracellular 
fate of FcR-bound ligands. 
Transport ofFcR to Lysosomes.  To confirm that the uptake of multivalent (but 
not monovalent) ligands correlates with  the transport of FeR to lysosomes, the 
subcellular localization  of the  receptor in  cells exposed to  various  ligands  was 
determined by Percoll gradient  centrifugation and  immunoprecipitation. J774 
cells were surface iodinated in the cold and then incubated at 37 °C for 0-2 h  in 
the presence of Fab,  Fab-gold, or IgG complexes.  In some experiments,  trace- 
iodinated  Fab  was  used  to  monitor ligand  distribution.  After centrifugation in 
Percoll,  ~2"~I-FcR was  immunoprecipitated  from  each  fraction  using  a  rabbit 
antireceptor antibody. Immunoprecipitates were analyzed by SDS-PAGE and the UKKONEN  ET  AL.  961 
FIGURE 5.  Immunoprecipitation of ~5I-labeled Fc receptor from Percoll gradient fractions. 
Monolayers of radioiodinated J774 cells in 6-cm plates were incubated in complete medium 
containing 2.4G2 Fab (3-5 #g/ml), IgG/DNP-BSA complexes (20 #g IgG/ml), or Fab-gold 
(3-5 #g/ml)  for 60  or  120  min  at  37°C.  Cells were then  harvested, homogenized, and 
centrifuged in 27% Percoll. Individual fractions were solubilized in buffer containing 0.5% 
Triton X-100 and  ~SI-FcR detected using a rabbit anti-FcR antibody. Immunoprecipitates 
were analyzed by SDS-PAGE and autoradiographed.  The lysosomes sedimented in fractions 
6-10, which contained the major peak of B-glucuronidase activity (Figs. 2 and 3). Fractions 
21-26  contained  the  plasma membrane/endosome  region  of the  gradient.  Labeled FcR 
electrophoresed as a broad  60-kD band (2,  3). Arrowheads indicate a presumptive 30-kD 
digestion intermediate of the receptor,  which was detected only in the lysosomal fractions. 
The additional labeled low molecular mass (25-30 kD) bands in panels B and E represent 1251- 
Fab tracer which was added in some experiments. Receptor-bound Fab is coprecipitated by 
the rabbit anti-FoR antibody under these conditions (11). These data are quantitated in Table 
1. 
radioactive bands excised from dried gels and quantitated.  The results of these 
experiments are shown in Fig. 5 and Table I. 
The amount of labeled 60-kD FcR precipitated from the lysosomal region of 
the gradient  (fractions  6-10)  was  significantly greater for cells incubated  with 
IgG complexes (Fig.  5,  C  and D)  or  Fab-gold  (Fig.  5,  E  and F) than  for cells 
incubated with monovalent Fab (Fig. 5, A and B). When expressed as a percentage 
of the total amount of 125I-FcR detected in each gradient, the fraction of receptor 
that cosedimented with lysosomes in cells exposed for 60 min to 2.4G2 Fab was 
only 4%,  while in cells exposed to either of the multivalent ligands,  I~SI-FcR in 
the lysosomal fractions accounted for ~25%  of total (Table I). The amount of 
125I-FcR in the high density fractions increased slightly between 60 and 120 min 
(to  13%  for  Fab-treated  cells  and  to  27-31%  for  IgG  complex  of Fab-gold- 
treated cells) (Table I). 
Although muhivalent ligands clearly increased the fraction of 125I-FcR present 
in  lysosomes,  it  was  always  exceeded by  the  amount  of receptor precipitated 
from  the  low  density  endosome/plasma  membrane  fractions (fractions  21-26) 
(Table I), suggesting that not all surface FcR had been transported to lysosomes. 
However, this finding might also reflect the selective loss of immunoprecipitable 962  MACROPHAGE Fc  RECEPTORS AND  Fc  RECEPTOR-BOUND  LIGANDS 
TABLE  I 
Distribution of l25I-FcR After Percoll Gradient Centrifugation 
Time of  Ligand used during incubation 
Gradient 
incuba-  fractions  IgG com- 
tion  2.4G2 Fab  Fab-gold  plexes 
1  6-10  4.0  25.6  24.8 
21-26  96.0  74.4  75.2 
2  6-10  13.2  31.2  27.0 
21-26  86.8  68.8  73.0 
Monolayers ofJ774 cells in 6-cm plates were radioiodinated at 4°C using 
lactoperoxidase and glucose oxidase. Cultures were then fed with warm 
complete medium containing  2.4G2  Fab  (3-5  #g/ml),  Fab-gold (3-5 
t~g/ml), or IgG/DNP-BSA complexes (20 #g/ml) and incubated for 1 or 2 
h at  37°C.  Cells were washed with cold PBS, harvested by scraping, 
homogenized, and centrifuged in Percoll density gradients. 12~I-FcR was 
immunoprecipitated from individual detergent-solubilized gradient frac- 
tions and displayed on SDS-polyacrylamide  gels (Fig. 5). Using autoradi- 
ographs of dried gels as templates, the radioactive bands (including the 
presumptive 30-kD digestion intermediate; see Fig. 5) were cut out and 
quantified. The amounts of ~SI-FcR immunoprecipitated from the lyso- 
somal region (fractions 6-10) and the endosome/plasma membrane region 
(fractions 21-26)  of the gradients were expressed as percentage of the 
total amount of labeled FcR recovered from each gradient. 
FcR  from  the  lysosomal  fractions  due  to  receptor  degradation.  That  such 
degradation occurred is supported by previous studies that documented a greatly 
increased rate of FcR turnover in cells exposed to IgG complexes (6). In addition, 
immunoprecipitation of ~25I-FcR from the high density fractions often yielded a 
presumptive 30-kD digestion intermediate corresponding to the transmembrane 
and cytoplasmic domains of the  60-kd receptor (3) (Fig.  5, arrows).  Since  IgG 
complexes accelerate the halftime for FcR degradation from >15 h to 4-5 h  (6), 
we estimate that after 2  h, ~25%  of the FcR would be lost due to degradation. 
Thus,  the  total  amount  of  labeled  receptor  either  degraded  or  present  in 
lysosomes after 2  h  in  multivalent  ligand  could account for up to  55%  of the 
initial amount of surface receptor, in general agreement with the percentage of 
surface FcR lost (65%) after 2  h  incubation in  IgG complexes (6). Exposure of 
cells to monovalent 2.4G2  Fab did not detectably increase the rate of 125I-FcR 
degradation relative to controls (unpublished results). 
Effect of  NH4 Cl, Monensin,  and Intermediate Temperature on FcR-mediated  Trans- 
port to Lysosomes.  The binding of IgG complexes to FcR is relatively insensitive 
to low pH;  <25%  of the  ligand  dissociates from cell surface  FcR during a  2-h 
incubation  at  0°C,  whether  at  neutral  or  acidic  pH  (pH  3.0-5.5)  (6).  Thus, 
unlike many ligands whose delivery to lysosomes is blocked by agents that elevate 
intravesicular pH (e.g., NH4CI and monensin) (19, 20), the interaction between 
IgG-complexes and  FcR  should  not  itself be  altered  by  treatment  with  such 
agents. 
To  determine  the  role  of acidic  pH  in  endosomes  and  lysosomes  on  the 
transport of FcR-bound iigands, J774 cells were treated with  10 mM NH4Ci or UKKONEN  ET  AL.  963 
20 #M monensin for 30-60 min at 37°C before the addition of 125I complexes 
(21).  After 90  rain  at  37°C,  the cells were homogenized and  centrifuged in 
Percoll density gradients.  As shown in  Fig.  6,  neither inhibitor prevented the 
transfer of the x2"~I-IgG complexes to high density lysosomes. Although the low 
density peaks containing endosomes and the plasma membrane were somewhat 
larger and broader than  in  the control gradient, subtilisin  treatment of intact 
cells at 4°C indicated that the percentage of t~sI-IgG complexes remaining on 
the cell surface was not affected by either drug; after 90  rain at 37°C  in  the 
presence or absence of inhibitors, only 20% of the cell-associated radiolabel was 
accessible to  removal by subtilisin.  Based on  the distribution  of lesI-IgG com- 
plexes in the Percoll gradient fractions (Fig. 6, A-C), it could be calculated that 
the  percentage  of radiolabel  in  endosomes  was  increased  in  monensin-  and 
NH4Cl-treated cells relative to  control  cells (35%  vs.  20%)  (Table  II).  These 
results  indicate  that  the  transport  of FcR-bound  ]igands  from endosomes to 
lysosomes does not depend absolutely on low intravesicular pH. Similarly, NH4CI 
did not inhibit the transport to lysosomes of a marker of fluid phase endocytosis, 
horseradish peroxidase (not shown). 
The  only  effective  inhibitor  of  IgG  complex  transport  to  lysosomes  was 
incubation at 17 °C. As shown in Fig. 6D, Percoll gradient centrifugation showed 
that little or no ligand reached the high density lysosomal fractions even after 
90 rain at 17 ° C. ~50% of the cell-associated radiolabel was intracellular (resistant 
to  removal by subtilisin)  at  this  time point.  Even after 4  h  at  17°C,  no  IgG 
complex degradation  was detected as TCA-soluble radiolabel  in  the medium, 
using either v'sI-IgG/DNP-BSA or IgG/125I-DNP-BSA as ligand. 
To  characterize  the  17°C  block  further,  cells  exposed  to  colloidal  gold- 
conjugated IgG complexes were examined by electron microscopy. After 1 h at 
the  intermediate  temperature,  gold  particles  were  found  in  electron  lucent 
vesicular and tubular endosomes usually in the peripheral cytoplasm. In contrast 
to the results obtained at 37°C (Fig. 1), IgG-gold internalized at 17°C was rarely 
observed in multivesicular endosomes. Moreover, when present in these struc- 
tures, the marker was usually associated with the endosome's limiting membrane 
rather than with the small internal vesicles as found in control cells and in cells 
treated with  NH4CI  or  monensin.  Fig.  7  compares  multivesicular endosomes 
containing IgG-gold which had been internalized at either 37°C  (Fig.  7A) or 
17°C  (Fig.  7B)  to  illustrate  the  different distributions  of the  marker  under 
conditions that permit or block ligand transport to lysosomes, respectively. 
Discussion 
The results presented here clarify several issues concerning the control of FcR 
traffic and cell surface expression during receptor-mediated endocytosis in J774 
cells. The most important of these regards the mechanism of FcR down-regula- 
tion and the principles underlying molecular sorting in endosomes. When taken 
together with previous reports (5, 6), the present data show that ligand valency 
is a key factor in determining whether internalized FcR are recycled back to the 
plasma membrane or are transported to lysosomes and degraded. We have found 
that FcR can mediate the endocytosis of both monovalent and multivalent ligands 
(monoclonal antireceptor  Fab  fragments and  Fab-gold  or  IgG  immune corn- 964  MACROPHAGE  Fc  RECEPTORS  AND  Fc  RECEPTOR-BOUND  LIGANDS 
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FIGURE 6.  Effect of NH4CI, monensin, and intermediate temperature (17°C) on the sedi- 
125  N  BSA m  Percoll  mentation of cell-associated  I-IgG/D  P-  "  density gradients. J774 cells in 10- 
cm dishes were incubated with I~sI-IgG/DNP-BSA for 90 rain at 37°C in complete medium 
(A), or in medium containing 10 mM NH4CI (B), or 20 #M monensin (C). The ceils in B and 
C were treated with the agents for 30 rain at 37°C before the addition of IgG complexes. One 
dish was incubated in complete medium at  17°C for 90 rain (D). The cells were harvested, 
homogenized, and the posmuclear supernatants were centrifuged in 27% Percoll as in Fig. 2. 
In the presence of NH4C1 (B) or monensin (C), most of the l~I-IgG complexes was found in 
the lysosomal fractions. In both cases, however, the low density plasma membrane/endosome 
peak was broader than in the control (A).  At  17°C  (D),  no radioactivity was found in the 
lysosomal fractions. 3-Glucuronidase activity was maximum at fractions 5-11 (peak at fraction 
7; not shown). UKKONEN  ET  AL. 
TABLE II 
Distribution of Cell-associated ~5l-IgG Complexes in J774 Cells 
Treated With Agents That Elevate Intravesicular pH 
With 10  With  20 #M  Compartment  Control  mM NH4CI  monensin 
Plasma membrane  22  23  24 
Endosomes  20  35  35 
Lysosomes  58  42  41 
J774 cell monolayers were incubated in medium containing 20 ug/ml J*sI- 
lgG/DNP-BSA in the presence or absence of 10 mM NH4C1 or 20 I,M 
monensin. After 90 min at 37°C, the amount of  plasma membrane-bound 
versus intracellular ligand was measured by determining the amount of 
~2~l-lgG released by subtilisin treatment  in  the cold (6). The cells on 
parallel plates were harvested by scraping, homogenized, and centrifuged 
in PercoH density gradients. The distribution of the l~sI-IgG complexes 
between the low density plasma membrane/endosome peak and the high 
density lysosome peak was obtained from gradient profiles such as those 
in Fig. 5. The amounts of radiolabel in fractions 5-13 (lysosomes)  and in 
fractions 14-29 (plasma membrane/endosomes) are exposed as percent- 
ages of the total gradient  radioactivity. The percentage of 125I-IgG in 
endosomes was obtained by subtracting the percentage of subtilisin-releas- 
able  radioactivity from  the  percentage  of radioactivity in  the  plasma 
membrane/endosome fractions. 
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plexes,  respectively).  Both  types  of ligand  are  delivered  to  endosomes where, 
unlike many other ligand-receptor systems, their dissociation from the receptor 
is not potentiated by the acidic endosomal pH.  Although  both ligands remain 
receptor-bound, their  intracellular destinations are distinct.  While monovalent 
ligand-FcR complexes are rapidly returned from endosomes to the cell surface, 
muitivalent  iigands  are  routed  together with  the  receptor to  lysosomes where 
both are degraded. 
Since monovalent Fab and multivalent Fab-gold conjugates by definition bind 
to the same determinant on the receptor, the "signal" for sorting cannot depend 
on  the  mode of attachment.  The  main  difference between  the  two ligands  is 
valency, suggesting that the cells can differentiate between FcR bound to oligo- 
meric and  monomeric  ligands  and  separate  them  from  each  other.  It  is  also 
significant that Fab-gold conjugates were as efficient as multivalent IgG immune 
complexes (the receptor's physiological ligand) at causing the transport of recep- 
tors to lysosomes. Thus,  the presence or absence of intact Fc domains is not a 
determining factor in  directing the  intracellular traffic of the receptor.  It also 
confirms that the Fab-gold bound and entered cells via FcR. In this context, it is 
important to stress that the colloidal gold preparations used in these experiments 
did not adsorb nonspecifically to the J774 cell surface; the binding of IgG/DNP- 
BSA-gold or Fab-gold could be inhibited by excess 2.4G2 IgG, and the adsorption 
of uncomplexed DNP-BSA-gold could not be detected. However, since we could 
not accurately measure the stoichiometry of the Fab-gold conjugates, and since 
some gold particles may have been internalized as small aggregates of 3-4 (Fig. 
4B,  inset),  determining  the  minimum  degree  of  valency  needed  to  trigger 966  MACROPHAGE  Fc  RECEPTORS  AND  Fc  RECEPTOR-BOUND  LIGANDS 
FIC,  UR~  7.  Localization of IgG/DNP-BSA-gold in endosomes at  37 °  and  17°C. J774  cells 
were incubated in colloidal gold-labeled lgG-complexes for 10 rain at 37°C (A) or for 1 b at 
17 °C (B).  As shown by Percoll gradient centrifugation (Figs.  2B and 6D), little if any ligand 
could  be  detected  in  bigb  density  lysosomes under  these  conditions. Thus,  virtually  all 
intracellular ligand was localized in endosomes. Most of the gold in the endosomes of cells 
incubated at 37°C was closely associated with the membranes of small vesicles  in the endosome 
lumen (A).  Note also the presence of gold in small  (50 nm diameter) vesicles and tubules in 
the vicinity of the larger endosome. In cells incubated at 17 °C, endosomes  containing internal 
vesicles were much less common; when gold was observed in these structures, it was more 
often associated with the endosome's limiting membrane than  with the membranes of the 
internal vesicles.  Bar, 0.2 ~m. UKKONEN ET AL.  967 
lysosomal transport  will  require  further study using covalently stabilized  Fab 
aggregates of defined size. 
It was not possible to perform direct comparisons between IgG complexes and 
the corresponding monomeric IgG. The FcR is specific for binding multivalent 
antibody-antigen complexes and exhibits only low affinity for IgG monomer (9, 
22, 23). Consequently, sufficient surface binding of labeled monomer could not 
be achieved to permit meaningful comparisons. To exclude the possibility that 
the low affinity of monomeric IgG was due to inability of the IgG to bind unless 
combined with its antigen, we prepared monovalent immune complexes: rabbit 
anti-DNP IgG complexed with either DNP-lysine or an octapeptide containing 
a  single amino terminal DNP-lysine. Neither of these complexes bound better 
than monomeric rabbit  125I-IGG or mouse myeloma 125I-IgG2b  (Ukkonen, P., 
and I. Mellman, unpublished results). 
How might ligand valency act to control FcR transport? Since all selectivity in 
membrane traffic must be manifested at the level of vesicle formation or vesicle- 
vesicle fusion, two general possibilities must be considered. First, the binding of 
multivalent iigands by FcR may simply alter one or more of the kinetic charac- 
teristics of receptor transport.  Multivalent ligands could, for instance, increase 
the rate of FcR internalization in coated pits without producing a corresponding 
increase in  the rate  of FcR  recycling back  to  the plasma  membrane. Such a 
situation would result in a net redistribution of receptors from the cell surface 
to the endosomal compartment (24) which, in turn, might increase the probability 
that  a  receptor  would  be  transferred  to  lysosomes.  Conversely,  multivalent 
ligands may decrease the rate at which FcR can recycle from endosomes to the 
cell surface, a  kinetic situation that would also result in a  net redistribution of 
FcR to the endosomal compartment. Such a situation would occur, for example, 
if receptors bound to multivalent ligands were sterically limited from entering 
the nascent recycling vesicles that must form at the endosome membrane. A 
third possibility is that muitivalent ligands may directly affect the rate of FcR 
transport  from endosomes to  lysosomes; e.g.,  they may provide a  signal  that 
increases the probability of fusion of FcR-containing endosomes (or endosome- 
derived transport vesicles) with lysosomes. 
Another point that  is illustrated by our results relates to  the role of acidic 
intravesicular pH in the transport of ligands to lysosomes. It is generally accepted 
that the acidic pH in endosomes is critical to the orderly traffic of membrane, 
receptors, and receptor-bound tigands during endocytosis (14,  15).  Low endo- 
somal pH facilitates the disruption of many ligand-receptor complexes, permit- 
ting the return  of free receptors to  the cell surface and the transport  of the 
discharged ligands to lysosomes. Lysosomal transport of many of these ligands is 
inhibited in cells treated with agents that elevate the pH of acidic intracellular 
vesicles,  suggesting that  the  transfer of endosomal  contents to  lysosomes, or 
perhaps endosome-lysosome fusion, is directly dependent of transmembrane pH 
gradients (19, 20). 
By studying a stable receptor-ligand complex whose dissociation is not poten- 
tiated by low pH we have been able to separate the effects of the inhibitors on 
receptor-ligand discharge from any direct effect on  lysosomal transport.  Our 
results show that acidic intravesicular pH is not an absolute requirement for the 968  MACROPHAGE  Fc  RECEPTORS  AND  Fc  RECEPTOR-BOUND  LIGANDS 
transfer of internalized macromolecules from endosomes to lysosomes. Neither 
the transport of IgG complexes nor of fluid phase markers of endosomal content 
(e.g.,  horseradish peroxidase)  was  blocked in J774  cells  treated  with  NH4C1. 
Similar results have been obtained for chorionic gonadotropin, another ligand 
which does not dissociate from its receptor at low pH (25), and for phagosome- 
lysosome fusion in macrophages (26). The role of low endosomal pH in control- 
ling intraceIlular transport during endocytosis may thus be limited to facilitating 
the discharge of acid-sensitive ligand-receptor complexes. Conceivably, the fail- 
ure of acid-dissociable ligands to reach lysosomes in the presence of the inhibitors 
may be an indirect result of the failure of the ligand to dissociate in endosomes. 
The intact receptor-ligand complexes could recycle between endosomes and the 
plasma membrane, as occurs for the monovalent Fab-FcR complex in NH4CI- 
treated ceils (5). 
Although  the  uptake  of IgG  complexes and  Fab-gold  is  characterized  by 
delivery of both  ligand and receptor to lysosomes, it should be noted that the 
ligand is transferred more efficiently than the receptor. After 2 h at 37°C, 70% 
of  the  cell-associated  ligand  and  no  more  than  55%  of  the  receptor  were 
transported to lysosomes. One explanation for this disparity is that a fraction of 
the receptor-bound ligand dissociates from FcR after internalization, allowing 
some of the receptors to recycle. Indeed, some dissociation is expected since the 
interaction  of  IgG  complexes  with  surface  FcR  displays  a  finite  (albeit  pH 
insensitive)  off-rate at  37°C  (6,  22).  The  incomplete transfer of receptor to 
lysosomes may also explain why IgG complexes fail to reduce the number of 
surface FcR by more than 65% even after 2 h at 37°C (6). 
In addition to the FcR, the intracellular traffic of several other receptors are 
known to  be modulated by the binding of nondissociable multivalent ligands. 
For instance, polyvalent antibodies to the mannose 6-phosphate receptor (27), 
the low density lipoprotein receptor (28), the epidermal growth factor receptor 
(29), and the transferrin receptor (30) prevent receptor recycling and/or result 
in receptor transport to lysosomes. Similar observations have been made using 
multivalent colloidal gold conjugates of transferrin and anti-transferrin receptor 
antibodies (3 l, 32). Like the anti-FcR Fab, unconjugated monovalent transferrin 
usually recycles between endosomes and the plasma membrane (33). Together, 
these findings suggest that the valency of receptor-ligand interactions and the 
oligomeric structure of membrane proteins should be evaluated when consider- 
ing the mechanisms that control membrane traffic. 
Su~m~ry 
Mouse macrophage Fc receptors specific for IgG1/IgG2b mediate the binding 
and  pinocytic  uptake  of soluble  IgG-containing antibody-antigen  complexes. 
Internalization of these multivalent IgG complexes is accompanied not only by 
the intracellular degradation of the ligand,  but also by a  net decrease in  the 
number of plasma membrane Fc receptors and an accelerated rate of receptor 
turnover. In contrast, internalized receptors bound to a monovalent ligand, the 
high affinity Fab fragment of the antireceptor mAb 2.4G2, escape degradation 
by rapidly recycling to the cell surface. In this paper, we have characterized the 
intracellular pathway involved in the endocytosis and transport of Fc receptors UKKONEN ET  AL.  969 
in the J774 macrophage cell line. The results show that the uptake of multivalent 
ligands follows the normal pathway of receptor-mediated endocytosis: internali- 
zation  in  clathrin-coated pits  and coated vesicles,  delivery to  endosomes, and 
finally to acid hydrolase-rich lysosomes.  Immunoprecipitation of radiolabeled 
receptor  from  Percoll  density  gradients  showed  that  endocytosis of the  IgG 
complexes also results in the concomitant transport of the receptor to lysosomes. 
Although uptake of the monovalent Fab fragment had no detectable effect on 
intracellular receptor distribution, preparations of 2.4G2  Fab rendered multi- 
valent by adsorption to colloidal gold were as effective as the IgG complexes at 
causing lysosomal accumulation of internalized receptors. Thus, it is likely that 
the down-regulation and degradation of Fc receptors  which occurs during the 
endocytosis of antibody-antigen complexes is due to the transport of internalized 
receptors to lysosomes. Moreover, the ability of certain Fc receptor-bound ligands 
to  interfere  with  receptor  recycling and trigger  lysosomal transport  seems  to 
depend on iigand valency rather than on the presence or absence of Fc domains 
on intact IgG molecules. 
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